NPI: 1699340927 · LEHIGHTON, PA 18235 · General Acute Care Hospital · NPI assigned 05/20/2021
Authorized official WOLFE, SCOTT controls 20+ related entities in our dataset. Read more
| Authorized Official | WOLFE, SCOTT (SENIOR VP EXEC ADMIN) |
| NPI Enumeration Date | 05/20/2021 |
Other providers sharing the same authorized official: WOLFE, SCOTT
| Year | Claims | Total Paid |
|---|---|---|
| 2021 | 558 | $25K |
| 2022 | 11,194 | $508K |
| 2023 | 12,395 | $499K |
| 2024 | 7,875 | $333K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99284 | Emergency department visit for the evaluation and management, high severity | 4,264 | 4,154 | $515K |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 4,729 | 4,661 | $408K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 1,399 | 1,364 | $248K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 521 | 505 | $59K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 5,173 | 5,025 | $29K |
| 80053 | Comprehensive metabolic panel | 2,972 | 2,869 | $29K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1,756 | 1,674 | $22K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 583 | 553 | $22K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 37 | 37 | $16K |
| 71045 | Radiologic examination, chest; single view | 860 | 842 | $7K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 38 | 37 | $2K |
| 80048 | Basic metabolic panel (calcium, ionized) | 192 | 190 | $2K |
| 83690 | 276 | 265 | $2K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 28 | 27 | $1K |
| 83735 | 84 | 83 | $700.63 | |
| 85610 | 149 | 143 | $487.10 | |
| 80050 | General health panel | 12 | 12 | $462.60 |
| 85730 | 71 | 64 | $383.53 | |
| 84484 | 12 | 12 | $116.85 | |
| 81001 | 28 | 28 | $69.70 | |
| 81003 | 13 | 12 | $32.68 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 597 | 529 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 918 | 869 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 949 | 707 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 416 | 310 | $0.00 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 174 | 160 | $0.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 2,420 | 2,189 | $0.00 |
| J3490 | Unclassified drugs | 48 | 39 | $0.00 |
| J2060 | Injection, lorazepam, 2 mg | 151 | 115 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 267 | 256 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 190 | 140 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 42 | 39 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 606 | 571 | $0.00 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 1,471 | 1,339 | $0.00 |
| J3475 | Injection, magnesium sulfate, per 500 mg | 172 | 161 | $0.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 267 | 246 | $0.00 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 61 | 52 | $0.00 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 27 | 25 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 19 | 16 | $0.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 30 | 26 | $0.00 |